首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro(1,2,4)triazino-(4,5-a)benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
【24h】

Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro(1,2,4)triazino-(4,5-a)benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.

机译:具有对癌细胞系优先的细胞毒性的2-芳基-4-(苯并咪唑-2-基)-1,2-二氢(1,2,4)三嗪基-(4,5-a)苯并咪唑-1-酮衍生物的合成。

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper we describe the preparation of some derivatives of 1,2,4-triazino[4,5-a]benzimidazol-1-ones (5 and 6), containing additional benzimidazole ring. These compounds were prepared using coupling reactions of diazonium salts with 1,1-bis(1-ethoxycarbonyl-benzimidazol-2-yl)methane (2) to obtain unstable hydrazones 4, which readily undergo cyclization. Interestingly, the selected compounds demonstrated preferential cytotoxic activities against human carcinoma and glioma cell lines compared with leukemic cells. They showed significant activity against multidrug-resistant P-glycoprotein expressing cell lines but had less effect on multidrug-resistance protein 1 positive and topoisomerase IIalpha negative leukemias.
机译:在本文中,我们描述了1,2,4-三嗪并[4,5-a]苯并咪唑-1-酮(5和6)的某些衍生物的制备,这些衍生物含有额外的苯并咪唑环。使用重氮盐与1,1-双(1-乙氧基羰基-苯并咪唑-2-基)甲烷(2)的偶联反应制备这些化合物,以获得不稳定的4,其易于环化。有趣的是,与白血病细胞相比,所选化合物对人癌和神经胶质瘤细胞系表现出优先的细胞毒活性。他们显示出对多药耐药的P-糖蛋白表达细胞系的显着活性,但对多药耐药蛋白1阳性和拓扑异构酶IIalpha阴性白血病的作用较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号